<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>"cellular reprogramming" AND (ageing OR aging) AND (mTOR OR senescence OR lysosome)<br><b>Date run: </b>2020/01/25<br><br><h2>PubMed Articles</h2> <br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31216022">XAB2 depletion induces intron retention in POLR2A to impair global transcription and promote cellular senescence.</a></b><br><b>Journal:</b> Nucleic Acids Res.<br><b>Two-year IF:</b> 11.14<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31242426">Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3.</a></b><br><b>Journal:</b> Cell Rep<br><b>Two-year IF:</b> 7.70<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31183403">The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype.</a></b><br><b>Journal:</b> Sci Adv<br><b>Two-year IF:</b> 12.53<br><br><b><a href="https://alexmakijokela.github.io/202001251408_cellular.html#pubmed">More Results...</a></b><br><br><h2>Companies</h2> <br><b><a href="https://alexmakijokela.github.io/202001251408_cellular.html#companies">More Results...</a></b><br><br><h2>Patents</h2> <br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6&p=1&f=G&l=50&d=PTXT&S1=((%22cellular+reprogramming%22+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))&OS="cellular+reprogramming"+AND+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome)&RS=(("cellular+reprogramming"+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))">Efficient method for reprogramming blood to induced pluripotent stem cells</a></b><br><b>Patent date:</b> March 5, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&p=1&f=G&l=50&d=PTXT&S1=((%22cellular+reprogramming%22+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))&OS="cellular+reprogramming"+AND+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome)&RS=(("cellular+reprogramming"+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))">Compositions comprising a mitofusin inhibitor for promoting cell reprogramming and a use thereof</a></b><br><b>Patent date:</b> December 3, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5&p=1&f=G&l=50&d=PTXT&S1=((%22cellular+reprogramming%22+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))&OS="cellular+reprogramming"+AND+(ageing+OR+aging)+AND+(mTOR+OR+senescence+OR+lysosome)&RS=(("cellular+reprogramming"+AND+(ageing+OR+aging))+AND+((mTOR+OR+senescence)+OR+lysosome))">Genomic engineering of pluripotent cells</a></b><br><b>Patent date:</b> May 14, 2019<br><br><b><a href="https://alexmakijokela.github.io/202001251408_cellular.html#patents">More Results...</a></b><br><br><br><b><a href="https://alexmakijokela.github.io/202001251408_cellular.html">Link to Full Search Results</a></b><br></body></html>